Three-Part Town Hall Series on Medical Devices and Biocompatibility

The U.S. Food and Drug Administration (FDA) will host a series of three town halls for industry and other interested parties to discuss various aspects of the biocompatibility evaluation of medical devices.  The series will cover biocompatibility risk assessment approaches with examples, chemical characterization, and toxicological risk assessments.  Registration is not required for these town halls.

Town Hall Topics and Dates:

Town Hall 1

• Topic: Biocompatibility Risk Assessment
• Date: September 9, 2026
• Time: 1:00 – 2:00 p.m. ET
• https://www.fda.gov/medical-devices/medical-devices-news-and-events/town-hall-biocompatibility-risk-assessment-09092026

Town Hall 2

• Topic: Biocompatibility and Chemical Characterization Testing - Extractions
• Date: September 23, 2026
• Time: 1:00 – 2:00 p.m. ET
• https://www.fda.gov/medical-devices/medical-devices-news-and-events/town-hall-biocompatibility-and-chemical-characterization-testing-extractions-09232026

Town Hall 3

• Topic: Biocompatibility and Toxicological Risk Assessment
• Date: October 7, 2026
• Time: 1:00 – 2:00 p.m. ET
• https://www.fda.gov/medical-devices/medical-devices-news-and-events/town-hall-biocompatibility-and-toxicological-risk-assessment-10072026

Questions?

If you have questions about this town hall series, contact the Division of Industry and Consumer Education.